QURE – uniQure N.V.
uniQure N.V.QURE
$13.86Name : uniQure N.V.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $758,814,208.00
EPSttm : -4.38
uniQure N.V.
$13.86
2.60%$0.37Float Short %
15.46
Margin Of Safety %
Put/Call OI Ratio
0.22
EPS Next Q Diff
0.1
EPS Last/This Y
1.92
EPS This/Next Y
0.47
Price
13.86
Target Price
35.5
Analyst Recom
1.29
Performance Q
5.6
Relative Volume
0.45
Beta
0.08
Ticker: QURE
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | QURE | 14.48 | 0.35 | 0.44 | 89958 |
| 2025-06-03 | QURE | 15.24 | 0.35 | 0.05 | 85902 |
| 2025-06-04 | QURE | 14.97 | 0.31 | 0.92 | 97673 |
| 2025-06-05 | QURE | 16.61 | 0.31 | 0.53 | 99154 |
| 2025-06-06 | QURE | 17.27 | 0.31 | 1.30 | 101245 |
| 2025-06-09 | QURE | 16.9 | 0.32 | 0.56 | 101884 |
| 2025-06-10 | QURE | 16.34 | 0.32 | 0.55 | 101772 |
| 2025-06-11 | QURE | 16.2 | 0.32 | 1.57 | 101703 |
| 2025-06-12 | QURE | 15.87 | 0.32 | 0.40 | 102136 |
| 2025-06-13 | QURE | 15.34 | 0.32 | 0.45 | 102164 |
| 2025-06-16 | QURE | 15.1 | 0.32 | 0.22 | 102364 |
| 2025-06-17 | QURE | 14.78 | 0.32 | 0.34 | 102611 |
| 2025-06-18 | QURE | 15.12 | 0.32 | 0.10 | 103031 |
| 2025-06-20 | QURE | 14.25 | 0.32 | 0.10 | 103018 |
| 2025-06-23 | QURE | 14.07 | 0.22 | 0.01 | 78125 |
| 2025-06-24 | QURE | 14.21 | 0.22 | 0.02 | 78426 |
| 2025-06-25 | QURE | 14.33 | 0.22 | 1.02 | 78196 |
| 2025-06-26 | QURE | 14.22 | 0.22 | 1.47 | 78163 |
| 2025-06-27 | QURE | 13.87 | 0.22 | 0.09 | 78589 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | QURE | 14.50 | 28.2 | 34.3 | -3.01 |
| 2025-06-03 | QURE | 15.16 | 28.3 | 25.0 | -3.01 |
| 2025-06-04 | QURE | 14.95 | 28.3 | 37.7 | -3.01 |
| 2025-06-05 | QURE | 16.61 | 28.6 | 12.4 | -3.01 |
| 2025-06-06 | QURE | 17.29 | 28.6 | 26.9 | -3.00 |
| 2025-06-09 | QURE | 16.90 | 28.6 | 38.8 | -3.00 |
| 2025-06-10 | QURE | 16.35 | 28.6 | 40.8 | -3.00 |
| 2025-06-11 | QURE | 16.20 | 28.6 | 36.4 | -3.00 |
| 2025-06-12 | QURE | 15.99 | 28.6 | 37.4 | -3.00 |
| 2025-06-13 | QURE | 15.33 | 28.6 | 42.8 | -3.00 |
| 2025-06-16 | QURE | 15.07 | 28.6 | 38.4 | -3.00 |
| 2025-06-17 | QURE | 14.78 | 28.6 | 39.1 | -3.00 |
| 2025-06-18 | QURE | 15.10 | 28.6 | 30.6 | -3.00 |
| 2025-06-20 | QURE | 14.21 | 28.6 | 46.7 | -3.00 |
| 2025-06-23 | QURE | 13.94 | 28.6 | 38.9 | -3.00 |
| 2025-06-24 | QURE | 14.21 | 28.6 | 30.9 | -3.00 |
| 2025-06-25 | QURE | 14.32 | 28.6 | 33.3 | -3.00 |
| 2025-06-26 | QURE | 14.23 | 28.6 | 36.2 | -3.00 |
| 2025-06-27 | QURE | 13.86 | 28.6 | 40.1 | -3.00 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | QURE | -3.85 | 32.70 | 14.18 |
| 2025-06-03 | QURE | -3.85 | 32.70 | 14.18 |
| 2025-06-04 | QURE | -3.85 | 32.70 | 14.18 |
| 2025-06-05 | QURE | -3.85 | 32.70 | 14.18 |
| 2025-06-06 | QURE | -3.85 | 32.70 | 14.18 |
| 2025-06-09 | QURE | -3.85 | 32.73 | 14.18 |
| 2025-06-10 | QURE | -3.85 | 32.73 | 14.18 |
| 2025-06-11 | QURE | -3.75 | 32.73 | 15.01 |
| 2025-06-12 | QURE | -3.75 | 32.73 | 15.01 |
| 2025-06-13 | QURE | -1.89 | 32.73 | 15.01 |
| 2025-06-16 | QURE | -1.89 | 32.72 | 15.01 |
| 2025-06-18 | QURE | -1.89 | 32.72 | 15.01 |
| 2025-06-20 | QURE | -1.89 | 32.72 | 15.01 |
| 2025-06-23 | QURE | -1.98 | 32.71 | 15.02 |
| 2025-06-24 | QURE | -1.96 | 32.71 | 15.02 |
| 2025-06-25 | QURE | -2.26 | 32.71 | 15.02 |
| 2025-06-26 | QURE | -2.26 | 32.71 | 15.46 |
| 2025-06-27 | QURE | -2.26 | 32.71 | 15.46 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.82
Avg. EPS Est. Current Quarter
-0.77
Avg. EPS Est. Next Quarter
-0.72
Insider Transactions
-2.26
Institutional Transactions
32.71
Beta
0.08
Average Sales Estimate Current Quarter
5
Average Sales Estimate Next Quarter
9
Fair Value
Quality Score
29
Growth Score
43
Sentiment Score
46
Actual DrawDown %
73.4
Max Drawdown 5-Year %
-92.5
Target Price
35.5
P/E
Forward P/E
PEG
P/S
37.57
P/B
22.51
P/Free Cash Flow
EPS
-4.39
Average EPS Est. Cur. Y
-3
EPS Next Y. (Est.)
-2.53
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1077.05
Relative Volume
0.45
Return on Equity vs Sector %
-669.8
Return on Equity vs Industry %
-651.9
EPS 1 7Days Diff
EPS 1 30Days Diff
0.61
EBIT Estimation
40.1
uniQure N.V.Sector: Healthcare
Industry: Biotechnology
Employees: 209
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
stock quote shares QURE – uniQure N.V. Stock Price stock today
news today QURE – uniQure N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QURE – uniQure N.V. yahoo finance google finance
stock history QURE – uniQure N.V. invest stock market
stock prices QURE premarket after hours
ticker QURE fair value insiders trading